🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06645405
Recruiting Not applicable

AI-Driven CTA Reconstruction for Intracranial LVO

NCT06645405 · tracked via the Priya Life Science China tracker
Sponsor
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Phase
Not applicable
Started
2024-10-20
Last updated
2024-10-16

Condition(s) studied

Acute Ischemic StrokeArtificial Intelligence (AI)Endovascular ThrombectomyCT Angiography

Investigational drug(s) / intervention(s)

AI algorithm

AI algorithm: Artificial intelligence algorithms in the automated reconstruction of intracranial large vessel occlusion (LVO)

Study summary

Acute ischemic stroke (AIS) caused by intracranial large vessel occlusion (LVO) in the anterior circulation significantly contributes to stroke-related disability and mortality. Recent randomized controlled trials have demonstrated substantial benefits of endovascular thrombectomy (EVT) when patients are appropriately triaged beforehand. However, accurately orienting the 'missed segment' during EVT remains challenging. Guide-wires often fail to navigate through the occlusion or are mistakenly directed into the small tranches or even cause vessel rupture. To address this clinical need, the investigators developed an artificial intelligence (AI) algorithm to automate the reconstruction of CT angiography (CTA), focusing on the occluded LVO segment. To evaluate the clinical utility of this AI algorithm, the investigators propose a prospective, stepped-wedge cluster-randomized study to determine whether integrating our AI algorithm into AIS care flow can reduce the time for first pass of the thrombus by improving the visualization of the occluded segment on CTA. Physicians will assess patient eligibility for thrombectomy, and all selected patients will receive standard care according to current guidelines. This approach is expected to enhance patient treatment outcomes for endovascular thrombectomy by leveraging readily available data.

Eligibility

Sex
ALL
Min age
18 Years
Max age
95 Years
Healthy volunteers
No
Inclusion Criteria: 1. Male or Female, 18 years of age or older. 2. Patients who present with signs and/or symptoms concerning acute ischemic stroke. 3. Patients who undergo noncontrast CT and CT angiography imaging. 4. Patients determined to have an intracranial large vessel occlusion (including the internal carotid artery, middle cerebral artery M1 segment, and M2 segment), and eligible for endovascular treatment. Exclusion Criteria 1\) CT imaging with severe motion artifacts.

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Shanghai Sixth People's Hospital Shanghai Shanghai Municipality Active Not Recruiting
Shanghai Sixth People's Hospital Shanghai China Recruiting

More Shanghai Jiao Tong University Affiliated Sixth People's Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06645405 on ClinicalTrials.gov ↗ ← All trials in China